AKT1 and breast neoplasm: Taken together, epoxyazadiradione suppresses cell migration, angiogenesis and breast tumor growth through downregulation of PI3K/Akt-mediated mitochondrial depolarization and induction of caspase-dependent apoptosis and blocking of AP-1 activation and expression of pro-angiogenesis and metastasis genes (Fig. 7h).